A new experimental brain implantation device, Blindsight, designed to restore vision has been awarded the US Food and Drug Administration’s (FDA) ‘breakthrough device’ designation.
The device was created by Elon Musk’s brain chip company, Neuralink, which specialises in developing a brain-chip interface that can be implanted within the skull.
Blindsight is designed to allow individuals who have lost both eyes and optic nerves to regain sight.